Predictors and clinical relevance of hemorrhagic transformation after endovascular therapy for anterior circulation large vessel occlusion strokes: A multicenter retrospective analysis of 1122 patients

Journal of NeuroInterventional Surgery

Volumn 7, Issue 1, 2015, Pages 16-21

  Nogueira, Raul G ^a   Gupta, Rishi ^a   Jovin, Tudor G ^b   Levy, Elad I ^c   Liebeskind, David S ^d   Zaidat, Osama O ^e   Rai, Ansaar ^f   Hirsch, Joshua A ^g   Hsu, Daniel P ^h   Rymer, Marilyn M ⁱ   Tayal, Ashis H ^j   Lin, Ridwan ^b   Natarajan, Sabareesh K ^c   Nanda, Ashish ^c   Tian, Melissa ^j   Hao, Qing ^d   Kalia, Junaid S ^e   Chen, Michael ^k   Abou Chebl, Alex ^l   Nguyen, Thanh N ^m   Yoo, Albert J ^g   more..

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f WEST VIRGINIA UNIVERSITY   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

ⁱ St Luke's Hospital   (United States)

^j ALLEGHENY GENERAL HOSPITAL   (United States)

^k RUSH UNIVERSITY   (United States)

^l UNIVERSITY OF LOUISVILLE HOSPITAL   (United States)

^m BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

AGE; AGED; ARTICLE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAROTID ANGIOPLASTY; CAROTID ARTERY STENTING; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENDOVASCULAR SURGERY; FEMALE; HEALTH CARE FACILITY; HEART ATRIUM FIBRILLATION; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; MAJOR CLINICAL STUDY; MALE; MECHANICAL THROMBECTOMY; MEDICAL DEVICE COMPLICATION; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PREDICTION; PROGNOSIS; RANKIN SCALE; RETROSPECTIVE STUDY; RISK ASSESSMENT; THROMBECTOMY; THROMBECTOMY DEVICE; TIME TO TREATMENT; ADVERSE EFFECTS; CHEMICALLY INDUCED; CLINICAL TRIAL; COMPLICATION; FIBRINOLYTIC THERAPY; MIDDLE AGED; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROCEDURES; STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; BRAIN ISCHEMIA; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84918567602     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2013-010743     Document Type: Article

References (25)

1. Lansberg MG, Albers GW, Wijman CA. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors. Cerebrovasc Dis 2007;24:1-10.
2. Khatri P, Wechsler LR, Broderick JP. Intracranial hemorrhage associated with revascularization therapies. Stroke 2007;38:431-40.
3. Gumbinger C, Gruschka P, Bottinger M, et al. Improved prediction of poor outcome after thrombolysis using conservative definitions of symptomatic hemorrhage. Stroke 2012;43:240-2.
4. Strbian D, Sairanen T, Meretoja A, et al. Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis. Neurology 2011;77:341-8.
5. Seet RC, Rabinstein AA. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions. Cerebrovasc Dis 2012;34:106-14.
6. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 2008;372:1303-9.
7. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29.
8. Menon BK, Saver JL, Prabhakaran S, et al. Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator. Stroke 2012;43:2293-9.
9. Mazya M, Egido JA, Ford GA, et al. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score. Stroke 2012;43:1524-31.
10. Strbian D, Engelter S, Michel P, et al. Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score. Ann Neurol 2012;71:634-41.
11. Fiorelli M, Bastianello S, Von Kummer R, et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 1999;30:2280-4.
12. Abou-Chebl A, Lin R, Hussain MS, et al. Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke: preliminary results from a retrospective, multicenter study. Stroke 2010;41:1175-9.
13. Molina CA, Alvarez-Sabin J, Montaner J, et al. Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke 2002;33:1551-6.
14. Dzialowski I, Pexman JH, Barber PA, et al. Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry. Stroke 2007;38:75-9.
15. IMS Study Investigators. Hemorrhage in the Interventional Management of Stroke study. Stroke 2006;37:847-51.
16. Hussain MS, Lin R, Cheng-Ching E, et al. Endovascular treatment of carotid embolic occlusions has a higher recanalization rate compared with cardioembolic occlusions. J Neurointerv Surg 2010;2:71-3.
17. Wahlgren N, Ahmed N, Eriksson N, et al. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST). Stroke 2008;39:3316-22.
18. Natarajan SK, Dandona P, Karmon Y, et al. Prediction of adverse outcomes by blood glucose level after endovascular therapy for acute ischemic stroke. J Neurosurg 2011;114:1785-99.
19. Shi ZS, Liebeskind DS, Loh Y, et al. Predictors of subarachnoid hemorrhage in acute ischemic stroke with endovascular therapy. Stroke 2010;41:2775-81.
20. Smith WS, Sung G, Saver J, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205-12.
21. Nogueira RG, Yoo AJ, Masrur S, et al. Safety of full-dose intravenous recombinant tissue plasminogen activator followed by multimodal endovascular therapy for acute ischemic stroke. J Neurointerv Surg 2013;5:298-301.
22. Vora NA, Gupta R, Thomas AJ, et al. Factors predicting hemorrhagic complications after multimodal reperfusion therapy for acute ischemic stroke. AJNR Am J Neuroradiol 2007;28:1391-4.
23. Kaur J, Zhao Z, Klein GM, et al. The neurotoxicity of tissue plasminogen activator? J Cereb Blood Flow Metab 2004;24:945-63.
24. Libman R, Kwiakowski T, Lyden P, et al. Asymptomatic hemorrhagic transformation of cerebral infarction does not worsen long-term outcome. J Stroke Cerebrovasc Dis 2005;14:50-4.
25. England TJ, Bath PM, Sare GM, et al. Asymptomatic hemorrhagic transformation of infarction and its relationship with functional outcome and stroke subtype: assessment from the Tinzaparin in Acute Ischaemic Stroke Trial. Stroke 2010;41:2834-9.